Oral Iron
Oral Iron is a pharmaceutical drug with 17 clinical trials. Historical success rate of 75.0%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
2
Mid Stage
12
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.0%
9 of 12 finished
25.0%
3 ended early
0
trials recruiting
17
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy of Treatment of Postpartum Anaemia With Intravenous Iron Versus Oral Iron in a Tertiary Hospital in South East, Nigeria.
Oral Liposomal Iron Versus Injectable Iron Sucrose for Anemia Treatment in Non-Dialysis Chronic Kidney Disease Patients
Efficacy and Safety of Lactoferrin in Heart Failure Patients
Sucrosomial Iron vs. Oral Iron Sulfate for the Treatment of Iron Deficiency Anemia in Patients With Ulcerative Colitis
A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease
Clinical Trials (17)
Efficacy of Treatment of Postpartum Anaemia With Intravenous Iron Versus Oral Iron in a Tertiary Hospital in South East, Nigeria.
Oral Liposomal Iron Versus Injectable Iron Sucrose for Anemia Treatment in Non-Dialysis Chronic Kidney Disease Patients
Efficacy and Safety of Lactoferrin in Heart Failure Patients
Sucrosomial Iron vs. Oral Iron Sulfate for the Treatment of Iron Deficiency Anemia in Patients With Ulcerative Colitis
A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease
A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease
Effect of Intravenous Iron Supplementation on Celiac Disease Remission (IRONCEL)
Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment
Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.
Oral Iron for Erythropoietic Protoporphyrias
Intravenous Versus Oral Iron Therapy in Hemodialysis Patients
A Randomized Trial of Oral Iron Therapy in Fibromyalgia
Health Economics of the Use of Ferrous Iron Salts in Primary Care in the UK.
Iron Supplementation for Acute Anemia After Postbariatric Abdominoplasty
Intravenous High Dose Iron in Blood Donors
2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.
Iron Therapy in Colo-Rectal Neoplasm and Iron Deficiency Anemia: Intravenous Iron Sucrose Versus Oral Ferrous Sulphate.
All 17 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 17